-
08-07-1999
A FEBRASGO abraçando o Brasil…
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(5):250-250
Abstract
A FEBRASGO abraçando o Brasil…
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(5):250-250
-
Original Article08-03-1999
Timing of surgery during menstrual cycle, late results and disease-free: survival rates in 130 patients with preast carcinoma
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):323-326
Abstract
Original ArticleTiming of surgery during menstrual cycle, late results and disease-free: survival rates in 130 patients with preast carcinoma
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):323-326
DOI 10.1590/S0100-72031999000600004
Views143See morePurpose: to offer new data for the conflicting reports which present different prognosis for patients with breast carcinoma, according to the timing of surgery in relation to the menstrual cycle. Patients and Methods: in a retrospective study on 451 premenopausal women with breast cancer, aged between 26 and 52 years, 130 cases were selected and followed for 60 months, at least. Sixty-eight were operated during the follicular phase and 62 in the luteal period, whose findings regarding clinical stages, axillary involvement and estrogen and progesterone hormonal receptor concentrations of the neoplasms were also analyzed. Results: the follow-up of 130 patients showed that 64.4% had a disease-free survival after five years and 43% exceeded 10 years. Subdividing the cases into 2 subgroups, according to the timing of surgery, the survival rates were different, 58.8% at 5 and 36.7% at 10 years, when the operation occurred in the follicular phase, and 70.9% and 50%, at 5 and 10 years, respectively, during the luteal period. Conclusions: in this study, the patients operated in the luteal phase reached higher survival rates than the women operated during the follicular period. However, these values were lower than those displayed by the classic prognostic factors of axillary involvement and tumor size.
-
Original Article08-03-1999
Pituitary down-regulation with the use of goserelin depot in cycles of controlled ovarian hyperstimulation for in vitro fertilization
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):311-315
Abstract
Original ArticlePituitary down-regulation with the use of goserelin depot in cycles of controlled ovarian hyperstimulation for in vitro fertilization
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):311-315
DOI 10.1590/S0100-72031999000600002
Views95See morePurpose: to verify the effects of the goserelin depot as GnRH agonist for hypophysis suppression, during the controlled ovarian hyperstimulation (COH) for in vitro fertilization and intrauterine embryo transfer (IVF & ET). Method: this is a prospective study of 110 cycles of 101 women. Goserelin depot was administered subcutaneously as a single dose; for some women (87 cycles) it was administered in the first phase of the menstrual cycle, and in 23 cycles it was administered in the luteal phase. The administration of menopausal gonadotropins was daily, until the identification of at least two follicles with a diameter equal to or larger than 18 mm; at this time the chorionic gonadotropin was administered and the follicular aspiration was programmed. Results: the women’s age average was 36.7 years (between 23 to 42 years). The main indications for IVF & ET were: tubo-peritoneal factor (75.2%), endometriosis (10.9%), ovulatory factor (7.9%), male factor (3.0%) and unexplained infertility (3.0%). Of the total of the cycles, 28 (25.5%) cycles were cancealed. In 7 cycles (8.04%), for which goserelin depot was administered in the first phase of the menstrual cycle, it was necessary to perform the ovarian cysts aspiration before beginning the ovulation induction. On the average, 3.3 embryos were transferred for each patient (1-5 embryos per woman). Of the total of 70 embryos transferred, 16 clinical pregnancies resulted (pregnancy rate: 22.85%). Conclusion: the goserelin depot administration is a useful alternative for pituitary suppression for IVF & ET, since its results are similar to those observed in the literature, and the patient does not need to come every day to receive medication, a fact of extreme importance in a public service.
-
08-02-1999
Aspectos histomorfométricos do endométrio de ratas adultas castradas após o uso de estrogênio, progestogênio e tamoxifeno
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):360-360
Abstract
Aspectos histomorfométricos do endométrio de ratas adultas castradas após o uso de estrogênio, progestogênio e tamoxifeno
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):360-360
DOI 10.1590/S0100-72031999000600013
Views54Aspectos Histomorfométricos do Endométrio de Ratas Adultas Castradas após o uso de Estrogênio, Progestogênio e Tamoxifeno[…]See more -
08-02-1999
Níveis de integrina anb3 no endométrio de mulheres usuárias do DIU T200
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):360-360
Abstract
Níveis de integrina anb3 no endométrio de mulheres usuárias do DIU T200
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):360-360
-
08-02-1999
Revisão e análise crítica de fibroadenoma da mama
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):359-359
Abstract
Revisão e análise crítica de fibroadenoma da mama
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):359-359
-
08-02-1999
Neoplasia intra-epitelial vulvar: estudo clínico e histopatológico
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):359-360
Abstract
Neoplasia intra-epitelial vulvar: estudo clínico e histopatológico
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):359-360
-
Case Report08-02-1999
Meconium peritonitis in the differential diagnosis of fetal ascites: a case report
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):353-357
Abstract
Case ReportMeconium peritonitis in the differential diagnosis of fetal ascites: a case report
Revista Brasileira de Ginecologia e Obstetrícia. 1999;21(6):353-357
DOI 10.1590/S0100-72031999000600009
Views98See moreIntroduction: meconium peritonitis as result of fetal intestinal perforation has a low incidence (1:30,000 deliveries) and high mortality (50% or more). Prenatal ultrasound findings include fetal ascites and intra-abdominal calcifications. Evidence suggests that prenatal diagnosis can improve postnatal prognosis. Case Report: R.C.M.S., 22 years, II pregnancy O para, presented ultrasound (12/02/98) with diagnosis of fetal ascites. Investigation for hydrops fetalis was performed and immune and nonimmune causes were excluded. Severe fetal ascites persisted on subsequent ultrasound examinations, without calcifications. Vaginal delivery occurred at 36 weeks (01/02/99), with polyhydramnios. Female neonate weighing 2,670 g, with signs of respiratory distress, abdominal distension and petechiae. Abdominal distension worsened progressively, with palpation of a petrous tumor in the right upper quadrant and elimination of white mucus at rectal examination. Radiological findings (01/04/99) were disseminated abdominal calcifications, intestinal dilatation and absence of gas at rectal ampulla. Exploratory laparotomy was indicated with diagnosis of meconium peritonitis. A giant meconium cyst and ileal atresia were observed and lysis of adhesions and ileostomy were performed. Initial postoperative evolution was satisfactory but was subsequently complicated by sepsis and neonatal death occurred (01/09/99). Conclusion: meconium peritonitis should be remembered at differential diagnosis of fetal ascites. In the present case, surgical indication could be anticipated if prenatal diagnosis were established, with improvement of neonatal evolution.
Search
Search in:
Tag Cloud
Pregnancy (252)Breast neoplasms (104)Pregnancy complications (104)Risk factors (103)Menopause (88)Ultrasonography (83)Cesarean section (78)Prenatal care (71)Endometriosis (70)Obesity (61)Infertility (57)Quality of life (55)prenatal diagnosis (51)Women's health (48)Maternal mortality (46)Postpartum period (46)Pregnant women (45)Breast (44)Prevalence (43)Uterine cervical neoplasms (43)